Biocytogen Pharmaceuticals, a biotechnology company focused on the generation and validation of novel antibody-based therapeutics and specialized animal models for partners worldwide, opened a new 37,000 sq.-ft. facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corp. The facility will triple Biocytogen Boston’s workspace, and includes a climate-controlled 4,000 cage vivarium, cell culture and procedure suites, and an open design concept to facilitate collaboration among empl...